Skyward Specialty Insurance Group
SKWDNASDAQUSD
- Source valuation snapshot. Not a live recalculation.
- Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
- Diluted earnings per share from the latest filed annual.
- $63.30 Prior regular-session close from the quote source.
- $61.77–$63.50 Regular-session low and high so far today.
- 310.6K Regular-session shares traded · Nov 11, 4:00 PM ET.
- Feb 22 projected Projected for 2027-02-22 from the company’s own results filings (SEC 8-K Item 2.02). The company has not confirmed the date.
- $40.60–$65.69 52-week trading low and high returned by the quote source.
Understand the Business
Why the Stock Moved
Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.
The core investment thesis
Own SKWD if its specialty-underwriting franchise keeps turning hard-to-place insurance demand into profitable, cash-generative premium growth rather than chasing volume late in the cycle.
SKWD price history
Loading recent earnings…
Investment thesis
What must happen next
Skyward continues to win broker-submitted specialty risks because standard insurance markets remain unable or unwilling to handle the same complexity at acceptable terms.StrengtheningMateriality: High
GAAP annual revenue increased from $550.2 million in FY2021 to $1.42 billion in FY2025. If this holds, premium growth can remain organic and franchise-led; if it breaks, growth becomes either slower or bought through weaker pricing.
Watch: Larger specialty competitors such as Kinsale, RLI, W. R. Berkley, or Markel begin taking Skyward-type accounts by offering broader limits or lower prices through the same brokers.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
GAAP annual revenue increased from $550.2 million in FY2021 to $1.42 billion in FY2025.
Open source ↗Skyward’s underwriting discipline remains strong enough that growth is selected risk, not underpriced volume taken late in the cycle.StrengtheningMateriality: High
GAAP annual net income rose from $38.3 million in FY2021 to $170.0 million in FY2025. This is the difference between compounding book value and merely borrowing future losses through today’s premium growth.
Watch: Casualty social inflation or adverse prior-year reserve development emerges in classes Skyward grew aggressively.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
GAAP annual net income rose from $38.3 million in FY2021 to $170.0 million in FY2025.
Open source ↗The insurance float model continues to fund growth internally because premium collections and loss-payment timing generate cash before claims consume it.StrengtheningMateriality: Medium
GAAP annual operating cash flow was positive in every year shown from FY2021 through FY2025. If cash generation holds, Skyward can expand capacity and investments without relying heavily on external capital; if it breaks, growth becomes balance-sheet constrained.
Watch: Paid losses accelerate faster than premium collections because claims severity or settlement speeds worsen.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
GAAP annual operating cash flow was positive in every year shown from FY2021 through FY2025.
Open source ↗Skyward’s capital base remains large enough to support underwriting capacity and financial-strength credibility as the company grows.StrengtheningMateriality: Medium
GAAP stockholders’ equity increased from $426.1 million at FY2021 year-end to $1.01 billion at FY2025 year-end. Specialty insurers can only write attractive business if brokers, insureds, regulators, and reinsurers trust their balance sheet.
Watch: A reserve charge or large loss materially reduces statutory surplus or reported equity.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
GAAP stockholders’ equity increased from $426.1 million at FY2021 year-end to $1.01 billion at FY2025 year-end.
Open source ↗Skyward’s growth remains accretive to owners because retained underwriting profits compound faster than dilution or capital needs.StrengtheningMateriality: Medium
GAAP annual diluted EPS increased from $1.18 in FY2021 to $4.07 in FY2025. For shareholders, the win is not bigger premium volume but higher earnings power per share.
Watch: Skyward issues significant equity to support underwriting growth or acquisitions at returns below its current earnings power.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
GAAP annual diluted EPS increased from $1.18 in FY2021 to $4.07 in FY2025.
Open source ↗
Full investment case & evidence
Loading the original research archive…
Original research
Skyward continues to win broker-submitted specialty risks because standard insurance markets remain unable or unwilling to handle the same complexity at acceptable terms. If this holds, premium growth can remain organic and franchise-led; if it breaks, growth becomes either slower or bought through weaker pricing.
Skyward’s underwriting discipline remains strong enough that growth is selected risk, not underpriced volume taken late in the cycle. This is the difference between compounding book value and merely borrowing future losses through today’s premium growth.
The insurance float model continues to fund growth internally because premium collections and loss-payment timing generate cash before claims consume it. If cash generation holds, Skyward can expand capacity and investments without relying heavily on external capital; if it breaks, growth becomes balance-sheet constrained.
Skyward’s capital base remains large enough to support underwriting capacity and financial-strength credibility as the company grows. Specialty insurers can only write attractive business if brokers, insureds, regulators, and reinsurers trust their balance sheet.
Skyward’s growth remains accretive to owners because retained underwriting profits compound faster than dilution or capital needs. For shareholders, the win is not bigger premium volume but higher earnings power per share.
All standing thesis claims
Original report summary
its specialty-underwriting franchise keeps turning hard-to-place insurance demand into profitable, cash-generative premium growth rather than chasing volume late in the cycle.
Bull case and bear case
Bull case and bear case for Skyward Specialty Insurance Group
Where the evidence on Skyward Specialty Insurance Group stands: Strengthening on the latest evidence (Nov 4, 2026). Of its 5 thesis points, 5 strengthening.
Bull case: what the evidence supports
Skyward continues to win broker-submitted specialty risks because standard insurance markets remain unable or unwilling to handle the same complexity at acceptable terms.
Skyward’s underwriting discipline remains strong enough that growth is selected risk, not underpriced volume taken late in the cycle.
The insurance float model continues to fund growth internally because premium collections and loss-payment timing generate cash before claims consume it.
Skyward’s capital base remains large enough to support underwriting capacity and financial-strength credibility as the company grows.
Skyward’s growth remains accretive to owners because retained underwriting profits compound faster than dilution or capital needs.
Bear case: what would count against it
Larger specialty competitors such as Kinsale, RLI, W. R. Berkley, or Markel begin taking Skyward-type accounts by offering broader limits or lower prices through the same brokers.
Casualty social inflation or adverse prior-year reserve development emerges in classes Skyward grew aggressively.
Paid losses accelerate faster than premium collections because claims severity or settlement speeds worsen.
Thesis-Break Engine
Thesis-break watch · Skyward Specialty Insurance Group
No break has crossed Skyward Specialty Insurance Group’s thesis. Its break conditions are checked against every new filing as it lands.
MARKET + FINANCIAL SNAPSHOT
The numbers behind the thesis
What Changed
- MixedDirector or principal officer change.
Skyward Specialty Insurance Group filed an SEC 8-K on 2026-08-20: Director or principal officer change. It is a dated development that tests the current thesis.
- MixedReported results of operations (earnings release).
Skyward Specialty Insurance Group filed an SEC 8-K on 2026-08-04: Reported results of operations (earnings release). It is a dated development that tests the current thesis.
- MixedOther material event.
Skyward Specialty Insurance Group filed an SEC 8-K on 2026-07-15: Other material event. It is a dated development that tests the current thesis.
Risks / falsifiers
What could break the thesis
- Larger specialty competitors such as Kinsale, RLI, W. R. Berkley, or Markel begin taking Skyward-type accounts by offering broader limits or lower prices through the same brokers.
- Casualty social inflation or adverse prior-year reserve development emerges in classes Skyward grew aggressively.
- Paid losses accelerate faster than premium collections because claims severity or settlement speeds worsen.
- A reserve charge or large loss materially reduces statutory surplus or reported equity.
- Skyward issues significant equity to support underwriting growth or acquisitions at returns below its current earnings power.
SKWD news
Loading headlines…
Financial statements
SKWD income statement
Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.
SKWD: quick answers
- When does Skyward Specialty Insurance Group (SKWD) report earnings next?
- Skyward Specialty Insurance Group's next results are projected for February 22, 2027, from the dates of its own results filings with the SEC. The company has not confirmed the date. It last reported on November 5, 2026. Earnings calendar
- What is SKWD's short interest?
- As of October 30, 2026, 2.0M SKWD shares were sold short, 4.50% of its shares outstanding, up 8.2% from the count before. At the stock's average daily volume that is 6.7 days to cover. FINRA publishes the count twice a month. SKWD short interest history
- Have members of Congress traded SKWD?
- Reports made public in the last 90 days disclose 2 trades in SKWD by 1 filer: 2 purchases and 0 sales. They are filed under the STOCK Act by members of Congress, the President and senior officials. Every disclosed SKWD trade